These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21415362)

  • 1. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.
    Wang T; Rohan TE; Gunter MJ; Xue X; Wactawski-Wende J; Rajpathak SN; Cushman M; Strickler HD; Kaplan RC; Wassertheil-Smoller S; Scherer PE; Ho GY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):971-7. PubMed ID: 21415362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    Gunter MJ; Wang T; Cushman M; Xue X; Wassertheil-Smoller S; Strickler HD; Rohan TE; Manson JE; McTiernan A; Kaplan RC; Scherer PE; Chlebowski RT; Snetselaar L; Wang D; Ho GY
    J Natl Cancer Inst; 2015 Sep; 107(9):. PubMed ID: 26185195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort--a factor analysis.
    Dossus L; Lukanova A; Rinaldi S; Allen N; Cust AE; Becker S; Tjonneland A; Hansen L; Overvad K; Chabbert-Buffet N; Mesrine S; Clavel-Chapelon F; Teucher B; Chang-Claude J; Boeing H; Drogan D; Trichopoulou A; Benetou V; Bamia C; Palli D; Agnoli C; Galasso R; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; van Duijnhoven FJ; Peeters PH; Onland-Moret NC; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Barricarte A; Lundin E; Khaw KT; Wareham N; Fedirko V; Romieu I; Romaguera D; Norat T; Riboli E; Kaaks R
    Am J Epidemiol; 2013 Apr; 177(8):787-99. PubMed ID: 23492765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
    J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.
    Brinton LA; Trabert B; Anderson GL; Falk RT; Felix AS; Fuhrman BJ; Gass ML; Kuller LH; Pfeiffer RM; Rohan TE; Strickler HD; Xu X; Wentzensen N
    Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1081-9. PubMed ID: 27197275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case-control study of inflammatory markers and the risk of endometrial cancer.
    Friedenreich CM; Langley AR; Speidel TP; Lau DC; Courneya KS; Csizmadi I; Magliocco AM; Yasui Y; Cook LS
    Eur J Cancer Prev; 2013 Jul; 22(4):374-9. PubMed ID: 23702681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study.
    Dossus L; Rinaldi S; Becker S; Lukanova A; Tjonneland A; Olsen A; Stegger J; Overvad K; Chabbert-Buffet N; Jimenez-Corona A; Clavel-Chapelon F; Rohrmann S; Teucher B; Boeing H; Schütze M; Trichopoulou A; Benetou V; Lagiou P; Palli D; Berrino F; Panico S; Tumino R; Sacerdote C; Redondo ML; Travier N; Sanchez MJ; Altzibar JM; Chirlaque MD; Ardanaz E; Bueno-de-Mesquita HB; van Duijnhoven FJ; Onland-Moret NC; Peeters PH; Hallmans G; Lundin E; Khaw KT; Wareham N; Allen N; Key TJ; Slimani N; Hainaut P; Romaguera D; Norat T; Riboli E; Kaaks R
    Endocr Relat Cancer; 2010 Dec; 17(4):1007-19. PubMed ID: 20843938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: Quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol.
    Dashti SG; Simpson JA; Viallon V; Karahalios A; Moreno-Betancur M; Brasky T; Pan K; Rohan TE; Shadyab AH; Thomson CA; Wild RA; Wassertheil-Smoller S; Ho GYF; Strickler HD; English DR; Gunter MJ
    Cancer Med; 2022 Feb; 11(4):1145-1159. PubMed ID: 35048536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B~FIT cohort.
    Dallal CM; Brinton LA; Bauer DC; Buist DS; Cauley JA; Hue TF; Lacroix A; Tice JA; Chia VM; Falk R; Pfeiffer R; Pollak M; Veenstra TD; Xu X; Lacey JV;
    Endocr Relat Cancer; 2013 Feb; 20(1):151-60. PubMed ID: 23222000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipokines linking obesity with colorectal cancer risk in postmenopausal women.
    Ho GY; Wang T; Gunter MJ; Strickler HD; Cushman M; Kaplan RC; Wassertheil-Smoller S; Xue X; Rajpathak SN; Chlebowski RT; Vitolins MZ; Scherer PE; Rohan TE
    Cancer Res; 2012 Jun; 72(12):3029-37. PubMed ID: 22511581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study.
    Pradhan AD; Manson JE; Rossouw JE; Siscovick DS; Mouton CP; Rifai N; Wallace RB; Jackson RD; Pettinger MB; Ridker PM
    JAMA; 2002 Aug; 288(8):980-7. PubMed ID: 12190368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Manson JE; Li J; Harris TG; Rohan TE; Xue X; Ho GY; Einstein MH; Kaplan RC; Burk RD; Wylie-Rosett J; Pollak MN; Anderson G; Howard BV; Strickler HD
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):921-9. PubMed ID: 18398032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case-control study of endogenous steroid hormones and endometrial cancer.
    Potischman N; Hoover RN; Brinton LA; Siiteri P; Dorgan JF; Swanson CA; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD; Persky V; Lurain JR
    J Natl Cancer Inst; 1996 Aug; 88(16):1127-35. PubMed ID: 8757192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women.
    Kabat GC; Kim MY; Lane DS; Zaslavsky O; Ho GYF; Luo J; Nicholson WK; Chlebowski RT; Barrington WE; Vitolins MZ; Lin X; Liu S; Rohan TE
    Eur J Cancer Prev; 2018 May; 27(3):261-268. PubMed ID: 29438162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.
    Lukanova A; Zeleniuch-Jacquotte A; Lundin E; Micheli A; Arslan AA; Rinaldi S; Muti P; Lenner P; Koenig KL; Biessy C; Krogh V; Riboli E; Shore RE; Stattin P; Berrino F; Hallmans G; Toniolo P; Kaaks R
    Int J Cancer; 2004 Jan; 108(2):262-8. PubMed ID: 14639613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Endogenous Pregnenolone, Progesterone, and Related Metabolites with Risk of Endometrial and Ovarian Cancers in Postmenopausal Women: The B
    Trabert B; Geczik AM; Bauer DC; Buist DSM; Cauley JA; Falk RT; Gierach GL; Hue TF; Lacey JV; LaCroix AZ; Michels KA; Tice JA; Xu X; Brinton LA; Dallal CM
    Cancer Epidemiol Biomarkers Prev; 2021 Nov; 30(11):2030-2037. PubMed ID: 34465588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of inflammation and breast cancer risk: a case-control study nested in the EPIC-Varese cohort.
    Agnoli C; Grioni S; Pala V; Allione A; Matullo G; Gaetano CD; Tagliabue G; Sieri S; Krogh V
    Sci Rep; 2017 Oct; 7(1):12708. PubMed ID: 28983080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediagnostic circulating inflammation markers and endometrial cancer risk in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial.
    Trabert B; Eldridge RC; Pfeiffer RM; Shiels MS; Kemp TJ; Guillemette C; Hartge P; Sherman ME; Brinton LA; Black A; Chaturvedi AK; Hildesheim A; Berndt SI; Safaeian M; Pinto L; Wentzensen N
    Int J Cancer; 2017 Feb; 140(3):600-610. PubMed ID: 27770434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women.
    Cust AE; Kaaks R; Friedenreich C; Bonnet F; Laville M; Lukanova A; Rinaldi S; Dossus L; Slimani N; Lundin E; Tjønneland A; Olsen A; Overvad K; Clavel-Chapelon F; Mesrine S; Joulin V; Linseisen J; Rohrmann S; Pischon T; Boeing H; Trichopoulos D; Trichopoulou A; Benetou V; Palli D; Berrino F; Tumino R; Sacerdote C; Mattiello A; Quirós JR; Mendez MA; Sánchez MJ; Larrañaga N; Tormo MJ; Ardanaz E; Bueno-de-Mesquita HB; Peeters PH; van Gils CH; Khaw KT; Bingham S; Allen N; Key T; Jenab M; Riboli E
    J Clin Endocrinol Metab; 2007 Jan; 92(1):255-63. PubMed ID: 17062769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.